(a) Risk of virologic suppression. n, number of individuals in the study cohort; uHR, univariable odds ratio; uOR, univariable odds ratio; aHR, adjusted hazard ratio from multivariable analyses; aOR, adjusted odds ratio from multivariable analyses; ES, effect size of risk ratio, reported as comparing females to males; 95% CI, 95% confidence interval; Favors Males, a risk ratio less than one indicates a decreased likelihood of virologic suppression for females compared to males; Favors Females, a risk ratio greater than one indicates an increased likelihood of virologic suppression for females compared to males; (b) Risk of virologic failure. n, number of individuals in the study cohort; uHR, univariable odds ratio; uOR, univariable odds ratio; aHR, adjusted hazard ratio from multivariable analyses; aOR, adjusted odds ratio from multivariable analyses; ES, effect size of risk ratio, reported as comparing females to males; 95% CI, 95% confidence interval; Favors Females, a risk ratio less than one indicates a decreased risk of virologic failure for females compared to males; Favors Males, a risk ratio greater than one indicates an increased risk of virologic failure for females compared to males.